Trial intelligence / Profile preview

Sevoflurane vs Propofol for ERCP Sedation

NCT05996588Phase 4Completed

Sponsor
Sindh Institute of Urology and Transplantation
Start
Jan 2022
Primary completion
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of sevoflurane in Procedural sedation (PS) (2 arms), sponsored by Sindh Institute of Urology and Transplantation. Primary endpoints: Ramsay Sedation Scale, Heart Rate and 3 more. Started Jan 2022; status: completed.

02

Drugs

sevoflurane
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT05996588.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05996588.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call